FirstView Market Insight Multiple Myeloma Market Review, Epidemiology And Market Forecast 2029 provides in depth understanding of historical and forecasted epidemiology along with the detailed market insights.The report covers detailed information on the disease, treatment algorithm, existing treatment and upcoming treatment regimens, unmet needs, market drivers, market barriers, sales trend and market revenue during study period 20182029.Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. In multiple myeloma, a type of white blood cell called a plasma cell multiplies unusually. Normally, they make antibodies that fight infections. But in multiple myeloma, they release too much protein called immunoglobulin into your bones and blood. It builds up throughout your body and causes organ damage.Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can cause complications.Signs and symptoms of multiple myeloma can vary and, early in the disease, there may be none.
Overview
This report contains comprehensive overview of disease including disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends, as well as details about treatment algorithms and treatment guidelines
Epidemiology Forecast
This section encompasses information on the incidence and prevalence of disease in EU5, US Japan. It also provides historical, current and forecasted estimates of diagnosed/treatable patient population.
Existing and upcoming treatment landscape
Captures the evolution of treatment paradigm including the current and emerging drug therapies. Provides information on the clinical trial results, mechanism of action, route of administration, therapeutic positioning, regulatory milestones and patent exclusivity. It gives insight into the potential therapeutic targets for drug development. The section also covers major events and latest happenings, deals and collaborations.
Market Size
This section of report will address the major issues, on the size and total addressable market share. This will help the companies to understand and visualize their business prospects and make major decisions based on the historical, current and forecasted market share across the globe. Analyze the commercial potential of the product as well as the disease/therapy area.
Market Trends Unmet needs
This section of the report helps to understand the market trend and opportunities by analyzing the impact of current therapies on the market, current and future unmet needs, drivers and barriers and demand of better technology. This is determined by analyzing the impact of various factors such as mechanism of action, route, cost of therapy, patient segmentation, existing available treatments, compliance and need of the market, expected launch timelines, competitors, brand value and KOLs perception.
List of products
Alkeran for Injection Melphalan Hydrochloride
Alkeran Tablets Melphalan
Aredia Pamidronate Disodium
BiCNU Carmustine
Bortezomib.
Carfilzomib.
Carmustine.
Cyclophosphamide.